KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 143 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $8,279,000 | -7.3% | 802,246 | -5.5% | 0.25% | -14.3% |
Q1 2021 | $8,928,000 | -38.1% | 848,707 | -8.9% | 0.29% | -39.8% |
Q4 2020 | $14,424,000 | +7.9% | 931,754 | +1.7% | 0.48% | -17.8% |
Q3 2020 | $13,370,000 | -29.9% | 915,760 | -9.1% | 0.58% | -32.2% |
Q2 2020 | $19,080,000 | +11.8% | 1,007,367 | +13.4% | 0.86% | -12.3% |
Q1 2020 | $17,064,000 | +24.3% | 888,284 | +24.0% | 0.98% | +64.4% |
Q4 2019 | $13,733,000 | +119.3% | 716,397 | +10.0% | 0.59% | +85.3% |
Q3 2019 | $6,263,000 | – | 651,050 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |